Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trissel, L.
Right arrow Articles by Martinez, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trissel, L.
Right arrow Articles by Martinez, J.
American Journal of Health-System Pharmacy, Vol 54, Issue 11, 1287-1292
Copyright © 1997 by American Society of Health-System Pharmacists

Articles

Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration

LA Trissel, DL Gilbert, and JF Martinez


The compatibility of a new formulation of injectable propofol with selected other drugs during simulated Y-site injection was studied. Two milliliters of undiluted propofol injectable emulsion was combined with 2 mL of each of 112 other drugs in 5% dextrose injection or 0.9% sodium chloride injection. The liquids were diluted with 6 mL of particle-free high-performance liquid chromatography (HPLC)-grade water and centrifuged for 20 minutes. A pipette connected to a vacuum line was used to remove the fat layer at the top and most of the aqueous phase. The remaining liquid was diluted with 9 mL of particle-free HPLC-grade water to facilitate visualization of any precipitate. The liquids were examined with the unaided eye in fluorescent light and with a Tyndall beam to enhance visualization of small particles. Samples were evaluated during the first 15 minutes and one hour after mixing. Propofol injectable emulsion was compatible with 98 of the 112 drugs testes. Fourteen drugs demonstrated incompatibilities, including precipitation, gel formation, and oiling out of cracked emulsions. During simulated Y-site injection, propofol injectable emulsion was compatible with most other drugs tested for one hour at approximately 23 degrees C
 



This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
K. Nemec, H. Kopelent-Frank, and R. Greif
Standardization of infusion solutions to reduce the risk of incompatibility
Am. J. Health Syst. Pharm., September 1, 2008; 65(17): 1648 - 1654.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
P. Chan, A. Bishop, T. C. Kupiec, L. A. Trissel, D. Gole, I. M. Jimidar, and H. Vermeersch
Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration
Am. J. Health Syst. Pharm., August 15, 2008; 65(16): 1545 - 1551.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
M. K. Brammer, P. Chan, K. Heatherly, C. Trusley, T. C. Kupiec, L. A. Trissel, P. A. Psathas, T. Gilmor, and D. Schaufelberger
Compatibility of doripenem with other drugs during simulated Y-site administration
Am. J. Health Syst. Pharm., July 1, 2008; 65(13): 1261 - 1265.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society of Health-System Pharmacists.